MedWatch

Coloplast starts share buyback program

The Danish medtech company has initiated a buyback of its own shares worth up to DKK 500m (USD 76.4m)

Photo: Coloplast / PR

In connection with the release of its 2021 full-year report, Coloplast announced that it would be starting a share buyback program totaling up to DKK 500m (USD 76.4m).

The program started today, Monday February 21, 2022, and will end on August 19, 2022 at the latest.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs